Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Alliance Global Partners upgraded Alimera Sciences (NASDAQ:ALIM) to Buy with a price target of $8.00, up from $4.50. Shares of Alimera Sciences are trading up 14.0% at $2.85 per share.
June 12, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alliance Global Partners upgraded Alimera Sciences to Buy with a price target of $8.00, a 180.7% increase from the current share price. Shares are trading up 14.0%.
The upgrade by Alliance Global Partners to Buy and the significant increase in the price target from $4.50 to $8.00 indicate a positive outlook for Alimera Sciences. This news has already impacted the stock price, with shares trading up 14.0%. The short-term impact is likely to be positive as investors react to the upgraded rating and new price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100